Termination of Early Pregnancy by the 3β-Hydroxysteroid Dehydrogenase Inhibitor Epostane

Authors:
  • CNCoenraad C.A. de Nooyer
    Coenraad C.A. de Nooyer
  • BRB. Ramanath Rao
    B. Ramanath Rao
  • GBGerrit T. Berends
    Gerrit T. Berends
  • LGLouis J.G. Gooren
    Louis J.G. Gooren
  • JJJannes Janssens
    Jannes Janssens

Abstract
Progesterone is essential to sustain pregnancy in the first eight weeks. Its synthesis requires the enzyme 3β-hydroxysteroid dehydrogenase (3-HSD). We tested the efficacy of an orally administered 3-HSD inhibitor, epostane, in terminating unwanted early pregnancy.

This publication has 13 references indexed in Scilit: